Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Allentown, Pennsylvania 18105


Purpose:

We hypothesized that weekly intramuscular injections of 17 hydroxyprogesterone caproate(17P) will reduce the number spontaneous preterm births prior to 35 weeks gestation when compared to cerclage therapy. The purpose of this study was to compare medical therapy with 17P to surgical therapy with transvaginal cerclage in patients with an ultrasound diagnosed short cervix and funnel in the mid-trimester.


Criteria:

Inclusion Criteria: - Ultrasonographic evidence of premature dilatation of the internal os - Prolapse of the chorio-amniotic membranes into the endocervical canal - Functional cervical length less than 25mm - Exacerbation of these ultrasound findings with transfundal and/or suprapubic pressure Exclusion Criteria: - Any fetal chromosomal or structural anomaly - Multiple gestation - Known allergy to progesterone - Ruptured membranes - Vaginal bleeding - Intra-amniotic infection (diagnosed clinically or by amniocentesis) - Prolapse of endocervical membranes beyond the external cervical os - Persistent uterine activity accompanied by cervical change - Obstetrically indicated delivery.


NCT ID:

NCT00694967


Primary Contact:

Principal Investigator
Orion Rust, M.D
Lehigh Valley Hospital


Backup Contact:

N/A


Location Contact:

Allentown, Pennsylvania 18105
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.